Inpharma Weekly

, Volume 1613, Issue 1, pp 11–11 | Cite as

Dasatinib tops imatinib for CML on economic level

Clinical study
  • 4 Downloads

Keywords

Sensitivity Analysis Health Outcome Imatinib Economic Evaluation Outcome Research 

Copyright information

© Adis International Ltd 2007

Personalised recommendations